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Abstract: The present article studied the use of industrialized phytotherapies by patients attended at the basic health units in Pinhais county, 
located in the metropolitan region of Curitiba, Paraná, Brazil. This is a quantitative, observational and cross-sectional study that was 
conducted by semi-structured questionnaire interviews that were used as a data collection instrument. The population sample consisted of 
267 patients from basic health care organizations. Regardless of gender or age, 56.2% of the interviewed participants reported using 
industrialized herbal medicines, of which 21.3% acquired their drugs from drugstores from around the county. Patients reported positive 
results using industrialized herbal medicines (89.33%), of whom women were predominant, making up (80%) (p<0.05). Among the drugs 
used by all the patients, “guaco” syrup was the most frequent (34%). The present study demonstrates the good acceptance by patients of 
treatments that involve integrative practices, such as herbal medicine, but when a drug has a vegetal origin, the idea that these products do 
not cause adverse effects persists. 
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Resumen: El presente articulo se estudio el uso de hierbas medicinales procesadas por pacientes tratados en unidades básicas de salud del 
município de Pinhais, en la región metropolitana de Curitiba, Paraná, Brasil. Se trata de un estudio cuantitativo, observacional y transversal, 
realizado por medio de  entrevistas que utilizan como instrumento de recolección de datos un cuestionario semi-estructurado. La población 
de la muestra consistió en 267 pacientes de atención básica a la salud. Independiente del sexo o de la edad, 56.2% de los entrevistados relató 
hacer uso de fitoterápicos industrializados, siendo que de los 21.3% hizo la adquisición en las farmacias de las unidades de salud del 
municipio. Los pacientes reportaron resultados positivos con el tratamiento realizado con fitoterápicos industrializados (89.33%). Entre ellos 
predominan las mujeres (80%) (p<0.05). Entre los medicamentos citados por los pacientes, el jarabe de guaco se mostró el más frecuente 
(34%). El presente estudio demuestra la buena aceptación por parte de los pacientes en realizar tratamientos que implican prácticas 
integrativas como la fitoterapia, pero, por poseer origen vegetal, todavía existe la idea de que estos productos no tienen la capacidad de 
causar efectos adversos. 
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INTRODUCTION 
The use of herbal medicines and medicinal plants in 
disease treatment is one of the oldest therapeutic 
practices of the humanity and has been used for 
centuries. This knowledge was built over the years 
with the contribution of popular knowledge and 
scientific experience (Ferreira et al., 2014). 
In ancient Egypt (1,500 BC) at approximately 
1873, the use of plants with therapeutic purposes in 
the Ebers' Papers was demonstrated, stating the use of 
phytotherapy by Egyptians. Approximately 2,500 
BC, there were evident advances in Traditional 
Chinese Medicine and the first records of the 
widespread use of medicinal plants were observed 
(Herbarium, 2012). 
The evident benefits of plants were 
corroborated by the identification of the Egyptian 
documents dating to 3,000 BC, which had already 
emphasized the use of natural products, such as 
opium by Sumerians and Babylonians (Herbarium, 
2012). 
The use of herbal medicines as a therapeutic 
resource was officially recognized by the World 
Health Organization (WHO) in 1978 (Brasil, 2001), 
reaffirming the aid of phytotherapies and medicinal 
plants in the maintenance and recovery of health 
(Brasil, 2001; Niero et al., 2003; Brasil, 2006a; 
Brasil, 2008). 
Currently, in many countries, most part of the 
population depends on the use of medicinal plants in 
health care. However, modern medicine stands side 
by side with traditional herbal medicine practice in 
maintaining its use for cultural factors and reasons. 
The results published in a systematic review 
aimed to investigate the prevalence of the 
complementary use of alternative medicines, 
including the use of herbal medicines by the general 
population, which demonstrated the prevalence of use 
in countries, such as Australia, Canada, Finland, 
Israel, United Kingdom and the United States (Harris 
& Rees, 2000). 
In general, there is ample use of medicinal 
plants by the populations of the different origins and 
regions of the world. Herbal products not registered 
as drugs in Canada are sold as food and therefore are 
exempt from the drug review process evaluating the 
efficacy and safety of the product (Kozyrskyj, 1997). 
In contrast, in the United States, most herbal products 
on the supermarket are marketed and regulated as 
dietetics and supplements, a category of products that 
does not require prior approval, being evaluated by 
reports of adverse effects (Chang, 1999). 
In countries such as Germany, herbal 
medicines are subject to strict manufacturing 
standards and sold as "phyto-medicines". In addition, 
they are subject to the same efficacy, safety and 
quality criteria as for other pharmaceutical products 
(Keller, 1991). The widespread use of herbal 
medicine in this country is evident, as approximately 
70% of the doctors prescribe it regularly. Germany 
has a long tradition of the consumption of natural 
products, which were also registered as traditional 
use products (Calixto, 2000; Herbarium, 2012). 
One of the main challenges for German 
primary health care in strengthening the use of herbal 
medicine is related to the promotion of knowledge 
and skills development in this area (Joos et al., 2012). 
In Cuba, the use of medicinal plants by 
patients treated in primary health care is promoted 
through the National Health System, which seeks to 
strengthen the implementation of alternative and 
complementary practices (Rivas et al., 2002). 
Similarly, in Chile in 1992, the Traditional 
Medicine Unit was created with the objective of 
incorporating traditional medicine with proven 
efficacy in health programmes to contribute to the 
establishment of this practice. Herbal medicinal 
products are legally differentiated into medicinal 
products and food products intended to cure, alleviate 
or prevent disease (Calixto, 2000). 
In other countries, such as Argentina, the 
distribution of some herbal medicines by the 
Medicinal Specialty Laboratory of the Ministry of 
Public Health of the Misiones province provides 
more than one treatment alternative for patients 
(Falkowski et al, 2008). 
The French Agency for Medicines (Agence 
du Médicament) grants marketing authorizations for 
herbal medicine based on abbreviated dossiers, which 
refer to traditional use. Traditional uses were first 
published in 1985 by the Ministry of Health and 
subsequently revised several times (AESGP, 1998). 
Since 1997, the French Pharmacopoeia had a list of 
local medicinal plants (Castot, 1997), which grouped 
454 herbs whose benefit/risk ratio is considered 
positive when traditionally used.  
Medicinal plants are distributed in several 
countries worldwide; however, they are more 
abundant in tropical countries, such as Brazil, which 
have approximately 22% of the world's biodiversity 
 Gribner et al.    Phytotherapics in the basic health care 
 
Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas/240 
 
at approximately 55 thousand plant species, 
presenting great potential for growth in the economic 
sector (Brasil, 2001). 
In Brazil, the strengthening and growth of 
implanting phytotherapy in the Unified Health 
System (SUS) was more evident after the 1980s, 
where several Resolutions, Portaries and Reports 
were elaborated focusing on the availability of 
phytotherapeutic drugs in basic health units (Brasil, 
2001). 
By the year 2006, through the Decree of the 
Presidency of the Republic No. 5.813, dated June 22, 
the National Policy of Medicinal Plants and 
Phytotherapeutics was created (Brasil, 2006a). In the 
same year, in cooperation with this programme, the 
insertion of phytotherapies in the SUS was carried 
out through Ministry of Health Decree No. 971 of 
May 3, 2006, which approved the National Policy on 
Integrative and Complementary Practices in SUS, 
which are the guidelines for the implementation of 
Medicinal Plants and Phytotherapy (Brasil, 2006b). 
The herbal medicines were redefined by 
Resolution No 26 on May 13, 2014, in which they are 
defined as technically elaborated, industrialized 
products, which originated as vegetal raw materials 
that were characterized by of their effectiveness and 
efficiency, proved by clinical evidence, related risks 
to its use, reproducibility and maintenance of its 
quality (Brasil, 2012; Brasil, 2014). 
Correspondingly, the National Sanitary 
Surveillance Agency also defines a traditional 
phytotherapeutic product, the safety and effectiveness 
of which can be proved by the means of data 
published in the technical-scientific literature, and 
there is no need for clinical evidence (Brasil, 2014). 
Thus, when the term "industrialized herbal 
medicine" is used here, the terms "phytotherapeutic 
medicines" and "traditional phytotherapeutic 
products" are included, according to RDC No. 26 of 
May 13, 2014. 
In this sense, this study performed an analysis 
about the use of industrialized herbal medicines by 
patients attended at basic health organizations of 
Pinhais county, located in the metropolitan region of 
Curitiba, Paraná, Brazil. 
 
MATERIALS AND METHODS 
This is a quantitative, observational and cross-
sectional study.  
Pinhais county has a total population 
estimated at 117,998 habitants according to the 
Brazilian Institute of Geography and Statistics 
(2010), being the fifth city in the number of 
inhabitants of the counties that compose the 
metropolitan region of Curitiba, which is composed 
of 29 municipalities. The county has 10 Family’s 
Health organizations, which are: Ana Neri, 
Esplanade, Maria Antonieta, Perdizes, Perneta, 
Tarumã, Tebas, Vargem Grande, Vila Amelia and 
Weissópolis. 
For the sample definition, a probabilistic 
study was chosen, with a random stratified sampling 
proportional, a margin of error of 6% and a 
confidence level of 95%. For the sample calculations, 
the number of visits performed by each basic health 
organization in 2014 was taken into account. 
The primary patient data collection was 
obtained by semi-structured interviews, during 
February and March 2016, in all the county health 
organizations according to the sample calculation. 
The sample was composed of a total of 267 
patients, who signed a Term of Free and Informed 
Consent after invitations and clarifications about the 
research objectives. 
The data collection instrument was 
previously evaluated through a pilot study involving 
10 patients from health organizations in Pinhais, 
which were not used to compose the final sample. 
This step was performed to check if the developed 
research instrument would be viable. For it is through 
the effective application of the questionnaire that one 
can verify flaws that can pass unnoticed by the 
researcher (Barbetta, 2011). 
The final script of the semi-structured 
interview covered the following topics: experiences 
using industrialized herbal medicines; ways of 
acquiring industrialized herbal medicine; 
improvement after the use of herbal medicine; and 
general characteristics, such as gender, age and 
schooling. In a complementary manner, the patient 
was asked if he or she used medicinal plants without 
medical indication. 
The interviews were randomly carried out by 
the researcher at the basic health organizations 
preceding physician attendance at the time of the 
withdrawal of medication in the pharmacy. 
The interviews had free time, with no refusal 
rate. Data regarding the interviews were analysed 
with the help of the Statistica 7.0 program. For the 
analysis of the association of the variables, a chi-
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square test was used. 
The study was authorized by the Municipal 
Health Department of Pinhais and approved by the 
Ethics Committee of the Federal University of Paraná 
- Health Sciences Sector, on December 11, 2015, 
under opinion 1,363,771 and CAAE 
49439615.0.0000.0102. 
 
 
 
TABLE 1 
Description of the characteristics of interviewed patients using industrialized phytotherapics 
 
Characteristics of patients 
 
f 
 
% 
MAKES PHYTOTERAPIC   
Yes 150 56,2 
No 117 43,8 
SEX   
Male 30 20 
Female 120 80 
AGE   
18-29 31 20,6 
30-49 51 34 
50-69 58 38,6 
70 or more 10 6,66 
SCHOOLING   
Elementary School 
 Incomplete 
Complete 
 
45 
28 
 
16,8 
10,4 
High school 
Incomplete 
Complete 
 
75 
82 
 
28 
30,7 
Higher education 29 10,8 
Did not know how to report 8 3 
( f ) Frequency. 
SOURCE: The author (2016). 
 
 
 
RESULTS AND DISCUSSION 
The population sample was composed of 267 patients 
interviewed in the health units of Pinhais county, 
including individuals over 18 years of age, of which 
80% were female and 20% were male, with different 
levels of schooling. 
The most prevalent age group was between 
50 and 69 years old (38.6%) compared to the ages of 
the patients interviewed with the use of herbal 
medicines, no significant statistical result was 
observed (p>0.05) (Table  No 1). 
Independent of gender or age, 56.2% of the 
individuals interviewed were reported to have used 
industrialized herbal medicines when necessary.  
When questioned about the place where they 
obtained these medicines, 21.3% reported that they 
were obtained in the pharmacies of the county health 
units studied. Countries, such as Cuba and Argentina, 
similarly seek to promote the use of medicinal plants 
by patients receiving primary health care, providing 
some options through the National Health System 
(Rivas et al., 2002) and Laboratory of Medicinal 
Specialties of the Ministry of Public Health of the 
Missões province of, providing one more alternative 
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treatment for patients (Falkowski, 2008). 
When we evaluated the schooling of patients 
using phytotherapeutics, it was observed that 30.7% 
of patients finished high school and 10.4% of patients 
who finished elementary school. No statistically 
significant relationship was observed between using 
phytotherapeutics and the schooling of the 
interviewees (p>0.05) (Table No 1). 
This result differs from a similar study (Silva, 
2003), carried out with patients using phytotherapy at 
the Basic Units of Family Health Care of Maracanaú, 
Ceará, in which it was observed that the majority of 
patients interviewed had only attended elementary 
school (75.7%). 
It is noted that the insertion of the 
phytotherapeutics in the routine consultations carried 
out in basic health care is still limited. Of the patients 
interviewed, only 20.2% had undergone medical 
consultations in which the professional indicated an 
industrialized herbal medicine to perform the therapy. 
This reinforces the lack of medical participation in 
the prescription of these drugs. In this case, the 
presence of self-medication could be observed, since 
56.2% of the individuals interviewed reported using 
industrialized herbal medicines when necessary. 
According to data from the World Health 
Organization (WHO), a large part of the population 
in developing countries uses traditional medicine to 
treat health problems, with 80% using traditional 
practices. Among these practices, 85% of the users 
used medicinal plants or their preparations to treat 
health problems, which makes traditional medicine 
complementary to basic health needs and basic health 
care (BRASIL, 2006a). 
At least one-third of American adults use 
some form of alternative therapy annually. In a study 
of patients with neurological diseases, 40% of the 
patients were reported to use at least one alternative 
therapy for the treatment of Parkinson's disease 
(Rajendran, 2001). 
In some countries such as Iraq, the preference 
for using natural products can also be observed by the 
medical team, which chooses to prescribe natural 
products. This fact was demonstrated in the city of 
Hawler (Iraq) where part of the medical team 
interviewed (47%) patients and opted to use herbal 
medicines for urological treatment (Mutalib, 2015). 
 The sale of medicinal plants in countries 
such as Germany is quite expressive, approximately 
600-700 plants are sold, contributing to the expansion 
of its use. In addition, 70% of physicians prescribe 
herbal medicines, where part of the annual sales are 
paid for by government health insurance 
(Blumenthal, 1988; Herbarium, 2012). 
In a complementary manner, in Germany, 
phytotherapy is known as one of the five main 
elements of classical naturopathy, showing an 
increase of users over the years and the percentage of 
German herbalists increased from 52% in 1970 to 
70% in 2010 (Joos et al., 2012). 
In the scope of the SUS, public policies, such 
as the National Policy of Medicinal Plants and 
Phytotherapeutics and the National Policy of 
Integrative and Complementary Practices in the SUS, 
reinforce the need and importance of valuing 
traditional knowledge, to stimulate research in the 
field of alternative medicine and contribute to 
rational use in the field of herbal medicine. In this 
way, the participation of health professionals who can 
contribute to the expansion and application of these 
policies is of fundamental importance, allowing the 
inclusion of phytotherapy in public health services in 
Brazil. 
Pinhais county has 3 herbal medicines in its 
Municipal Relation of Essential Medicines 
(REMUME), including guaco syrup (Mikania 
glomerata Spreng.), holy thorn capsules (Maytenus 
officinalis Mabb.) and soy isoflavone capsules 
(Glycine max (L.) Merr.). 
In general, 89.3% of patients who reported 
the use of herbal medicines stated improvement after 
the treatment, characterizing this therapy as an 
effective alternative. Other studies have shown that 
there is acceptance of the use of herbal medicines by 
primary health care patients (Silva, 2003; Tomazzoni 
et al., 2006; Oliveira et al., 2012). 
When asked about the need to stop treatment 
because they did not achieve the desired 
improvement, 83.3% said that there was no need to 
replace the herbal medicine with other treatment 
alternatives. Some patients reported more benefits 
when using herbal medicines, citing relevant 
advantages when compared to other products and 
synthetic drugs (Table No 2). 
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Table No 2 
Advantages cited by patients using phytotherapy 
 
Reasons claimed by patients for use of herbal medicines 
 
Frequency 
 
% 
"It has no chemistry: it is "natural " 73 48.6 
"It is same as a common medicine (synthetic medicine)" 30 20 
"Less aggressive to the organism" 30 20 
"It takes time to work, but it has a good result" 7 4.6 
"Cheaper" 2 1.3 
SOURCE: The author (2016). 
 
 
The fact that these industrialized herbal 
medicines originated from plants facilitates their 
acceptance because they are associated with a natural 
origin and supposedly safe and without 
contraindications, meaning that they do not contain 
"chemicals". However, although the population 
generally believes that herbal medicines have no side 
effects, cause less dependence and are less 
aggressive, studies confirm that plants have toxic 
constituents that can cause health risks (Calixto, 
2001; Gomes et al., 2005). 
Tomazzoni et al. (2006) similarly observed 
that the preference for medicinal plant use is related 
to the patients' belief and association that plants have 
healing properties, are more reliable, effective and 
have fewer side effects than other synthetic 
medicines. 
Corroborating this point, the interviewed 
patients at the University Hospital of Heidelberg, 
Germany, reported that the use of herbal medicine is 
better because it has more satisfactory effects and 
fewer side effects compared to conventional medicine 
(Joos et al., 2012). 
Similarly, in a national survey conducted in 
Italy, 15.6% of the patients interviewed in the Italian 
population reported having used non-conventional 
therapy, citing phytotherapy (4.8%). The main reason 
for such use was concern about the potential toxicity 
of "conventional medicine" (Menniti-Ippolito et al., 
2002). 
Following the same line, some patients 
believe that the chemistry of the synthetic products 
can be harmful to the organism, promoting more side 
effects, rather than contributing to the improvement 
of a certain pathology (Teixeira & Lefèvre, 2001). 
However, it is known that there is a group of 
plants that have a toxic capacity and their use has 
been classified as insecure (Klepser & Klepser, 
1999). 
Of the 43.8% of the patients who did not use 
herbal products, 96.6% favoured their use when 
necessary, and 3.4% would not accept phytotherapy 
as an alternative treatment. Some justifications for 
non-adherence to phytotherapeutic use has been 
reported as a "delay in working" or that "it does not 
work". 
All interviewees cited an example of 
industrialized herbal medicine, which they had 
already used or were using (Table No 3). 
It is possible to observe the predominance of 
guaco syrup utilization by the interviewed patients 
(34%). Its therapeutic use is due to popular 
knowledge associated with scientific knowledge 
(Alcantara et al., 2015), which proves and indicates 
its action as an expectorant and bronchodilator, 
among other indications, provided by the presence of 
chemical compounds, such as coumarins (Cavallazzi, 
2006; Amaral et al., 2009; Brasil, 2001; Rename, 
2015). This may contribute to the fact that this is the 
medicine noted by the interviewed patients. 
In Germany, the therapeutic use of herbal 
medicines is common, with several indications, 
including respiratory tract infections, cardiovascular 
diseases and gastrointestinal symptoms (Calixto, 
2000; Joos et al., 2012). 
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Table No 3 
Industrialized phytotherapies cited by interviewed patients 
Name Pharmaceutical 
form 
Frequency % 
Arnica (Arnica montana L.) Ointment 2 1.3 
Indian chestnut (Aesculus hippocastanum L.) Capsules 11 7.3 
Espinheira Santa (Maytenus officinalis Mabb.) Capsules 11 7.3 
Figatil® (Cynara scolymus L., Peumus boldus 
Molina) 
Syrup 1 0.6 
Garra do Diabo (Harpagophytum procumbens 
DC. ex Meissn. and Harpagophytum zeyheri 
Decne) 
Capsules 5 3.3 
Ginkgo (Ginkgo biloba L.) Capsules 9 6.0 
Guaco (Mikania glomerata Spreng.) Syrup 51 34 
Hedera helix L. Syrup 5 3.3 
Soy Isoflavone (Glycine max (L.) Merr.) Capsules 17 11.3 
Passiflora (Passiflora incarnata L.) Capsules / Syrup 17 11.3 
Sominex® (Valeriana officinalis L., Passiflora 
incarnata L., Crataegus oxyacantha L.) 
Capsules 7 4.6 
Tribulus terrestris L. Capsules 4 2.6 
Valerian (Valeriana officinalis L.) Capsules 10 6.6 
SOURCE: The author (2016) 
 
 
The most common condition for people in the United 
States that use alternative therapies, such as herbal 
medicine, include back problems, anxiety, 
depression, and headaches (Eisenberg et al., 1998). 
When the use of these drugs by the patients 
interviewed could be observed, the consumption of 
products did not agree with the municipality studied. 
Complementarily, it is evident that even those 
medicines made available by the county are not fully 
acquired in the health organization, including one of 
the 34% of patients who use guaco and 14.66% had 
access to the drug by SUS. Regarding soy isoflavone, 
of the 11.33% who use it, 4% reported access in the 
health units of Pinhais. Finally, when evaluating the 
acquisition of espinheira santa, 2.66% of the 7.33% 
who use herbal medicines obtained this medicine free 
in the SUS units. 
It is not possible to ignore the fact that self-
medication occurs among patients, which may be 
influenced by the recommendation of lay people or 
previous medical prescriptions (Arrais et al., 1997; 
Vilarino et al., 1998). This may explain, in part, the 
non-acquisition of all the industrialized herbal 
medicines in the health units studied, which the 
county of Pinhais agreed with. 
One of the concerns is that the vast majority 
of patients using medicinal plants without their 
physician’s knowledge, as they are often encouraged 
by family, friends and the media (Rajendran et al., 
2001; Paula et al., 2012). 
It is evident the industrialized herbal 
medicines are predominantly used in the population 
between 50-69 years of age (38.6%). An increase in 
the number of users of industrialized plants and 
herbal products in older age groups has been 
observed. This was found by Genovés et al. (2001), 
who identified a higher consumption of medicinal 
plants in groups aged between 45 and 64 years. 
This behaviour may be related to the cultural 
and historical factor that involves the use of herbal 
medicines in the treatment of several diseases (Leite, 
2005), which may favour the use of these products 
according to an increase in the age group of the 
studied group. Complementarily, the elderly use 
health services more frequently, being in a group that 
is commonly diagnosed with various chronic diseases 
(Chaimowicz, 1997; Veras, 2009). 
By crossing the data obtained in the gender of 
the patients interviewed with the use of industrialized 
herbal products, it can be observed that there is a 
 Gribner et al.    Phytotherapics in the basic health care 
 
Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas/245 
 
significant statistical relationship (p<0.05), 
demonstrating that women use more industrialized 
herbal products compared to men (Table No 1). 
It has been observed in this study that the 
majority of interviewees who reported using 
industrialized herbal medicines as well as medicinal 
plants were female. These characteristics were agree 
with other studies. Silva (2003) reported the use of 
herbal medicines in basic health care in the city of 
Maracanaú-Ceará, where 85.4% of the patients 
interviewed were female. Studies have shown that 
there is a greater prevalence of drug use by women in 
relation to men (Bertoldi et al., 2004; Oliveira et al., 
2012; Tavares et al., 2015) 
Regarding the user profile, a systematic study 
realized by Frass et al. (2012) assessed the use of 
complementary and alternative medicine by the 
interviewees. From the survey conducted, the authors 
found that women were more prone to use these 
therapies compared to men. 
The results obtained could indicate that the 
gender of the patients could be considered a 
determinant factor for the use of industrialized herbal 
medicines. This may be related with a greater 
frequency of women seeking medical care and health 
care because they are more concerned about their 
health. It may also be related with greater health 
programme offerings to the female public (Bertoldi et 
al., 2004). 
The lower percentages of herbal medicine use 
observed in the group of men may be related to 
cultural situations, which require men to seek less 
primary health care services, that relate the disease to 
weakness and insecurity, leading to the devaluation 
of self-care (Figueiredo, 2005; Gomes et al., 2007) 
When asked if they used medicinal plants for self-
medication, 81.65% of the interviewed patients 
reported using it when necessary to treat health 
problems. 
The use of medicinal plants is common in 
other countries, such as Canada, where 546 medicinal 
plants traditionally used by aboriginal forests in 
Canada were identified (Uprety et al., 2012). 
Great satisfaction with the use of medicinal 
plants was observed. Paula et al. (2012) report that 
37% of patients used medicinal plants for oral 
treatments and that of these were satisfied with the 
results reached and that there were no adverse effects 
during treatment. 
 
FINAL CONSIDERATIONS 
In a similar way to that observed in other countries, 
there was good acceptance of industrialized herbal 
medicines by the patients to during treatments once 
these treatments demonstrated efficacy and safety, 
according to the users interviewed. 
The use of phytotherapeutics was more 
extensive in women than in men, and schooling and 
age were not statistically relevant regarding the use of 
herbal medicines. There is a strong cultural factor due 
to the old belief that "natural" products do not harm 
health, as demonstrated by the increasing tendency to 
use medicinal plants. 
The patients interviewed received 
prescriptions for phytotherapeutics, which were 
different from those made available by the 
municipality studied. This demonstrates the need to 
review and expand the list of herbal medicines 
offered and standardized in the health units of the 
evaluated county. 
In addition, it is important to improve the 
relationship between the doctor and the patient so that 
there is a reduction in self-medication, ensuring 
increased safety and effectiveness in the performed 
therapy. 
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